Findings

What do systematic reviews say?

8 questions · 8 findings · 4 reviews · Headline outcomes only

No studies found 4 · 50%GRADE not reported 0 · 0%Very low 4 · 50%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Adverse events · women with endometriosis

The review found no eligible studies for this question.

1 finding from 1 review

Pentoxifylline for the treatment of endometriosis‐associated pain and infertility 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adverse events · women with endometriosis

The review found no eligible studies for this question.

1 finding from 1 review

Pentoxifylline for the treatment of endometriosis‐associated pain and infertility 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious adverse events (number) · participants with severe alcoholic hepatitis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious adverse events (proportion) · participants with severe alcoholic hepatitis

It is very uncertain whether pentoxifylline changes serious adverse events (proportion) compared with no intervention (very low certainty).

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
OR 1.07 [0.76, 1.51]
1 study · 545 participants
Very low

Serious adverse events (proportion) · participants with alcoholic hepatitis (all severity)

It is very uncertain whether pentoxifylline changes serious adverse events (proportion) compared with no intervention (very low certainty).

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
OR 1.07 [0.76, 1.51]
1 study · 545 participants
Very low

Primary outcome 3: Adverse events · ulceration and other skin changes caused by nerve damage in leprosy

1 finding from 1 review

Interventions for ulceration and other skin changes caused by nerve damage in leprosy 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

Adverse events (participants) · people with critical limb ischaemia

It is very uncertain whether prostanoids changes adverse events (participants) compared with pentoxifylline (very low certainty).

1 finding from 1 review

Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
RR 0.6 [0.24, 1.47]
1 study · 70 participants
Very low